ABSTRACT
Hidradenitis suppurativa (HS) is a chronic, inflammatory follicular disorder that most commonly involves the intertriginous areas. It is characterized by recurrent nodules that may progress into deeper abscesses and sinus tracts. Treatment is challenging and often involves a combination of lifestyle modifications, medical therapies, and procedures to control symptoms. Deroofing is a tissue-saving surgical technique that has been well studied in adults and in our clinical experience is an important adjunct therapy in pediatric patients with moderate-to-severe HS. We describe the step-by-step process of deroofing, including surgical clinical pearls specific to the pediatric population.
Subject(s)
Hidradenitis Suppurativa , Adult , Child , Combined Modality Therapy , Hidradenitis Suppurativa/drug therapy , HumansABSTRACT
ABSTRACT: Hidradenitis suppurativa (HS) is a chronic and recurrent inflammatory skin condition resulting in the formation of nodules, sinus tracts, and abscesses in intertriginous areas. We provide recommendations for the management of children presenting to the emergency department with acute HS flares, based on a review of literature and insights from our own clinical experience. The purpose of the recommendations is to educate clinicians on specific considerations that should be made when caring for children with HS.
Subject(s)
Hidradenitis Suppurativa , Child , Emergency Service, Hospital , Hidradenitis Suppurativa/diagnosis , Hidradenitis Suppurativa/therapy , HumansSubject(s)
Granulomatosis, Orofacial/drug therapy , Granulomatosis, Orofacial/pathology , Immunosuppressive Agents/therapeutic use , Mycophenolic Acid/analogs & derivatives , Administration, Oral , Biopsy, Needle , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Follow-Up Studies , Granulomatosis, Orofacial/diagnosis , Humans , Immunohistochemistry , Middle Aged , Mycophenolic Acid/therapeutic use , Severity of Illness Index , Treatment OutcomeABSTRACT
Optimal management of atopic dermatitis (AD) requires patients to adhere to self-care behaviors. Technologies, such as cell phones, have been widely adopted in the USA and have potential to reinforce positive health behaviors. We conducted a pilot study with 25 adolescents and adults age 14 years and older [mean 30.5 yrs, SD 13.4] with AD. Daily text messages (TMs) that provided medication reminders and AD education were sent for six weeks to participants. Our goals were to (1) measure changes in pre- and posttest scores in treatment adherence, self-care behaviors, disease severity, and quality of life and (2) assess the usability and satisfaction of the TM system. Significant improvements in treatment adherence, self-care behaviors, skin severity, and quality of life (P ≤ .001, .002, <.001, and .014, resp.) were noted postintervention. User feedback on the TM system was positive with 88% and 92% of participants reporting that the reminder TMs and educational TMs were helpful, respectively. In conclusion, study participants were receptive to using TMs as a reminder aid and educational tool. The positive trends observed are promising and lay the ground work for further studies needed to elucidate the full potential of this simple and cost-effective intervention.
